TGFB1 and Hepatic fibrosis: In our study, it was found that treatment of rats with ICQA could significantly and dose -dependently inhibit the expression of COL1α1, TGF-β1 and TIMP-1 at both mRNA and protein levels, which indicated the potential therapeutic action of ICQA for liver fibrosis.